To determine the effect of primary tamoxifen treatment on the vascularity of breast cancers.

被引:0
|
作者
Marson, LP
Kurian, K
Miller, WR
Dixon, JM
机构
[1] Western Gen Hosp, Dept Pathol, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Western Gen Hosp, Edinburgh Breast Unit, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P101
引用
收藏
页码:50 / 50
页数:1
相关论文
共 50 条
  • [31] Tamoxifen as primary treatment of breast cancer in elderly patients
    Ciatto, S
    Cirillo, A
    Confortini, M
    Cardillo, CD
    NEOPLASMA, 1996, 43 (01) : 43 - 45
  • [32] Tamoxifen as the primary treatment in elderly patients with breast cancer
    Hooper, SB
    Hill, ADK
    Kennedy, S
    Dijkstra, B
    Kelly, LM
    McDermott, EWM
    O'Higgins, N
    IRISH JOURNAL OF MEDICAL SCIENCE, 2002, 171 (01) : 28 - 30
  • [33] ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER - OCCURRENCE OF NEW PRIMARY CANCERS
    FORNANDER, T
    CEDERMARK, B
    MATTSSON, A
    SKOOG, L
    THEVE, T
    ASKERGREN, J
    RUTQVIST, LE
    GLAS, U
    SILFVERSWARD, C
    SOMELL, A
    WILKING, N
    HJALMAR, ML
    LANCET, 1989, 1 (8630): : 117 - 120
  • [34] Resemblance of breast cancer to known viral cancers.
    Friedenson, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Clonal evolution of proliferative lesions into breast cancers.
    Nishimura, Tomomi
    Kakiuchi, Nobuyuki
    Yoshida, Kenichi
    Takeuchi, Yasuhide
    Maeda, Hirona
    Shiozawa, Yusuke
    Nakagawa, Masahiro M.
    Ochi, Yotaro
    Kawata, Yukiko
    Aoki, Kosuke
    Hirata, Masahiro
    Kataoka, Tatsuki R.
    Sakurai, Takaki
    Baba, Satoko
    Shiraishi, Yuichi
    Chiba, Kenichi
    Takeuchi, Kengo
    Haga, Hironori
    Miyano, Satoru
    Toi, Masakazu
    Ogawa, Seishi
    CANCER RESEARCH, 2021, 81 (13)
  • [36] Multiple primary cancers. A 6 years review
    Oliveira, ML
    Matos, LC
    Nogueira, F
    DeAbreu, MC
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 307 - 310
  • [37] Conservation treatment intensified with tamoxifen and CAF chemotherapy for subareolar breast cancers
    Ogawa, Y
    Nishioka, A
    Inomata, T
    Tsuboi, N
    Hayase, N
    Fukumoto, M
    Yoshida, S
    Tohchika, N
    Tanaka, Y
    Kumon, M
    ONCOLOGY REPORTS, 1998, 5 (06) : 1337 - 1341
  • [38] Allelic losses of the FHIT gene in breast cancers.
    Saboorian, MH
    Wistuba, I
    Virmani, AK
    AhmadianTehrani, M
    ONeill
    Minna, JD
    Gazdar, AF
    LABORATORY INVESTIGATION, 1997, 76 (01) : 124 - 124
  • [39] The effect of tamoxifen treatment on MUC-1 expression in primary breast cancer.
    Hanson, JM
    Browell, DA
    Cunliffe, WJ
    Young, JR
    Pearson, JP
    Varma, JS
    Allen, A
    Higgs, MJ
    BRITISH JOURNAL OF CANCER, 1998, 78 : 13 - 13
  • [40] Histone deacetylase inhibitors and the treatment of cancers.
    Rifkind, RA
    Richon, V
    Breslow, R
    Marks, PA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U45 - U46